Business Context and Reporting Period
Globus Medical, Inc. (GMED), a Delaware corporation, filed this Form 8-K on August 6, 2020. The report details the entry into a material definitive agreement regarding corporate financing.
Key Financial Metrics and Debt
- Debt Facility: Entered into a $125.0 million revolving credit facility with Citizens Bank, N.A.
- Letters of Credit: $25.0 million of the facility is designated for letters of credit.
- Term: The facility is available until August 5, 2021.
- Security: The Revolving Credit Facility is unsecured.
- Interest Rate: Loans bear interest at a base rate or Adjusted LIBOR Rate plus an applicable margin.
- Prepayment: Voluntary prepayments and commitment reductions are permitted without prepayment fees.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or existing liquidity positions as this is a current report on a specific event rather than a periodic financial statement.
Material Changes
The primary material change is the establishment of new borrowing capacity. The Company and its subsidiary, Globus Medical North America, Inc., are now borrowers under the new Credit Agreement, replacing or supplementing prior financing arrangements for general corporate purposes.
Guidance, Risks, and Covenants
- Covenants: The agreement includes financial covenants, specifically a maximum leverage ratio.
- Restrictions: Limitations are placed on liens, fundamental changes, and changes in the nature of the business.
- Compliance: The agreement requires compliance with anti-corruption and anti-money laundering laws.
- Events of Default: Standard representations, warranties, and events of default apply as set forth in the full agreement.
Investor Verification Checklist
- Verify the specific "applicable margin" and "base rate" definitions in the full Credit Agreement (Exhibit 10.1) to calculate potential interest costs.
- Confirm the specific threshold for the "maximum leverage ratio" covenant to assess financial flexibility.
- Review the full text of the agreement for any cross-default provisions that could impact other debt obligations.
- Monitor future filings to determine if the Company draws on the facility or utilizes the letter of credit portion.